• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

SHP:LN

2,925.000 GBp 25.000 0.86%

As of 11:35:29 ET on 04/17/2014.

Snapshot for Shire PLC (SHP)

Open: 2,905.000 Day's Range: 2,893.000 - 2,927.000 Volume: 1,459,819
Previous Close: 2,900.000 52wk Range: 1,853.000 - 3,444.000 1-Yr Rtn: +49.28%

Stock Chart for SHP

No chart data available.
  • SHP:LN 2,925.000
  • 1D
  • 1M
  • 1Y
2,900.000
Interactive SHP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SHP

Current P/E Ratio (ttm) 23.6907
Estimated P/E(12/2014) 15.5907
Relative P/E vs. UKX 1.3311
Earnings Per Share (USD) (ttm) 2.0730
Est. EPS (USD) (12/2014) 3.1500
Est. PEG Ratio 1.1830
Market Cap (M GBP) 17,225.15
Shares Outstanding (M) 588.89
30 Day Average Volume 2,164,053
Price/Book (mrq) 5.3458
Price/Sale (ttm) 5.4476
Dividend Indicated Gross Yield 0.42%
Cash Dividend (GBp) 10.2100
Dividend Ex-Date 03/05/2014
5 Year Dividend Growth 13.16%
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SHP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SHP

Shire PLC markets, licenses and develops prescription medicines. The Group focuses its operations on attention deficit and hyperactivity disorders, human genetic therapies, gastrointestinal, and renal diseases.

Flemming OrnskovChief Executive OfficerJames BowlingInterim CFO/Senior VP/Controller
Tatjana MaySecretary/General Counsel
More Company Profile & Key Executives for SHP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil